UMLS. CSP-HL7-ICD9CM-NCI-NDFRT-RXNORM - Terms starting with ‘C’

Dictionaries Armenian-English English-Armenian MeSH Feedback

%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

C C- C1 C3 C5 C6 C7 CA CB CC CD CE CF CG CH CI CJ CK CL CM CN CO CP CQ CR CS CT CU CV CW CX CY CZ

selected terms: 8,755

<< Prev ▫ 1 ▫ 2 ▫ 3 ▫ 4 ▫ 5 ▫ 6 ▫ 7 ▫ .. ▫ 88 ▫ Next >>

page 4 of 88

301. CA IN SITU BRONCHUS/LUNG (UMLS (ICD9CM) C0154071) =Neoplastic Process	351. cachexia [state of general ill health characterized by malnutrition, weakness, and emaciation; occurs during the course of a chronic disease. ( CSP )] (UMLS (CSP) C0006625) =Sign or Symptom =Emaciation; Clinical Finding
302. CA IN SITU CERVIX UTERI [Stage 0 includes: (Tis, N0, M0). Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) - 2003 ( NCI )] (UMLS (ICD9CM) C0851140) Carcinoma in situ of Cervix; Carcinoma in situ of Cervix Uteri; Carcinoma in situ of the Cervix; Carcinoma in situ of the Cervix Uteri; Carcinoma in situ of the Uterine Cervix; Carcinoma in situ of Uterine Cervix; Cervical cancer stage 0; Cervical Carcinoma in situ; Cervical Intraepithelial Neoplasia Grade 3; Cervical Severe More…	352. Cachil DeHe Band of Wintun Indians of the Colusa I (UMLS (HL7) C1554244) =Population Group =NativeEntityContiguous;
303. CA IN SITU COLON [Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ: intraepithelial or invasion of lamina propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.)-2003 ( NCI )] (UMLS (ICD9CM) C0154061) =Neoplastic Process	353. Caco-2 Cell [Human colonic ADENOCARCINOMA cells that are able to express differentiation features characteristic of mature intestinal cells, such as ENTEROCYTES. These cells are valuable in vitro tools for studies related to intestinal cell function and differentiation. ( MSH )] (UMLS (NCI) C0282560) =Cell ;
304. CA IN SITU ESOPHAGUS [Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) - 2003 ( NCI )] (UMLS (ICD9CM) C0154059) =Neoplastic Process	354. CACO3/VIT-D (UMLS (NCI) C0677766) =Therapeutic or Preventive Procedure
305. CA IN SITU EYE [ ] (UMLS (ICD9CM) C0154094) =Neoplastic Process	355. CAD [computer hardware, database, software or program used by medical and health personnel to assist in patient diagnostic testing; for recommended schedules of therapy use COMPUTER ASSISTED PATIENT CARE. ( CSP )] (UMLS (NCI) C0011905) =Diagnostic Procedure =Diagnosed; computer program; biomedical automation;
306. CA IN SITU EYELID [ ] (UMLS (ICD9CM) C1112527) Carcinoma in situ of eyelid, including canthus =Neoplastic Process	356. CAD (UMLS (NCI) C0170509) =Therapeutic or Preventive Procedure
307. CA IN SITU FEM GEN NEC [ ] (UMLS (ICD9CM) C1955739) Carcinoma in situ of other female genital organ; =Neoplastic Process	357. CAD [This gene is involved in nucleotide biosynthesis. ( NCI )] (UMLS (NCI) C1413078) CAD Gene; Carbamoyl-Phosphate Synthetase 2, Aspartate Transcarbamylase, and Dihydroorotase Gene =Gene or Genome
308. CA IN SITU FEM GEN NOS [ ] (UMLS (ICD9CM) C1955737) Carcinoma in situ of unspecified female genital organ; =Neoplastic Process	358. CAD (coronary artery disease) [Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. ( MSH )] (UMLS (CSP) C1956346) coronary artery disease; =Disease or Syndrome
309. CA IN SITU GI NEC/NOS (UMLS (ICD9CM) C0154067) =Neoplastic Process	359. cadaver [A dead body, usually a human body. ( MSH )] (UMLS (CSP) C0006629) =Anatomical Structure =Dead; =Postmortem Changes;
310. CA IN SITU LARYNX [Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.)-2003 ( NCI )] (UMLS (ICD9CM) C0154069) =Neoplastic Process	360. Cadaver donor (UMLS (HL7) C1548660) =Idea or Concept =Patient_s Relationship to Insured;
311. CA IN SITU LIVER/BILIARY [ ] (UMLS (ICD9CM) C0496854) =Neoplastic Process	361. Caddo (UMLS (HL7) C0574547) =Language =SouthernCaddoan;
312. CA IN SITU MALE GEN NEC [ ] (UMLS (ICD9CM) C0154090) =Neoplastic Process	362. Caddo Indian Tribe of Oklahoma (UMLS (HL7) C1554245) =Population Group =NativeEntityContiguous;
313. CA IN SITU NEC (UMLS (ICD9CM) C0007100) =Neoplastic Process ;	363. Caddoan (UMLS (HL7) C1698049) =Language ; =AmericanIndianAlaskaNativeLanguages; =SouthernCaddoan; NorthernCaddoan
314. CA IN SITU NOS [(kar-sin-O-ma in SYE-too) Cancer that involves only the cells in which it began and that has not spread to neighboring tissues. ( NCI )] (UMLS (ICD9CM) C0007099) =Neoplastic Process ; =carcinoma; =Cervical Dysplasia; PIN	364. cadherin [family of cell surface glycoproteins, first identified in vertebrates, that mediate calcium dependent, homophilic cell adhesion and thereby control tissue morphogenesis. ( CSP )] (UMLS (CSP) C0006631) =Amino Acid, Peptide, or Protein; Biologically Active Substance ; =Adhesion Molecule;
315. CA IN SITU ORAL CAV/PHAR (UMLS (ICD9CM) C0154058) =Neoplastic Process	365. Cadherin 1, Type 1, E-Cadherin (Epithelial) Gene [This gene plays a role in cell-cell adhesion and loss of function contributes to the progression of many carcinomas. ( NCI )] (UMLS (NCI) C0694872) =Gene or Genome
316. CA IN SITU RECTUM [Stage 0 includes: (Tis, N0, M0). Tis: Carcinoma in situ: intraepithelial or invasion of the lamina propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.)-2003 ( NCI )] (UMLS (ICD9CM) C0154062) =Neoplastic Process	366. Cadherin 13, H-Cadherin (Heart) Gene [This gene is a mediator of cell-cell adhesion and a negative regulator of neural growth. ( NCI )] (UMLS (NCI) C1332728) CDH13; CDH13 Gene; =Gene or Genome ;
317. CA IN SITU RESP SYS NEC (UMLS (ICD9CM) C0154072) =Neoplastic Process	367. Cadherin 3, Type 1, P-Cadherin (Placental) Gene [This gene is involved in the regulation of calcium-dependent cell-cell adhesion. ( NCI )] (UMLS (NCI) C1337110) CDH3; CDH3 Gene; =Gene or Genome
318. CA IN SITU RESP SYS NOS [ ] (UMLS (ICD9CM) C0348402) =Neoplastic Process	368. Cadherin 5, Type 2, VE-Cadherin (Vascular Epithelium) Gene [This gene plays a role in cellular adhesion and endothelial cell cohesion. ( NCI )] (UMLS (NCI) C1332729) CDH5; CDH5 Gene; =Gene or Genome ;
319. CA IN SITU SCALP (UMLS (ICD9CM) C0154078) =Neoplastic Process	369. Cadherin EGF LAG Seven-Pass G-Type Receptor 1 [Cadherin EGF LAG Seven-Pass G-Type Receptor 1, encoded by the human CELSR1 gene, is a G-Protein Coupled Receptor that may have an important role in cell/cell signaling during nervous system formation. It is an integral membrane protein with seven transmembrane domains, multiple cadherin repeats, EGF-like repeats, and laminin A G-type repeats. Two isoforms (1 and 2) may be produced by alternative splicing. The CELSR1 gene is developmentally regulated and neural-specific and the protein plays an unspecified role in early embryogenesis. (From LocusLink, Swiss-Prot, PubMed and NCI) ( NCI )] (UMLS (NCI) C1335562) CELSR1; Flamingo (Drosophila) Homolog; Protocadherin Flamingo 2; =Amino Acid, Peptide, or Protein; Receptor
320. CA IN SITU SKIN ARM (UMLS (ICD9CM) C0154080) =Neoplastic Process	370. Cadherin Family Memebr 12 [Encoded by human RET Gene, Tyrosine-Protein Kinase Receptor RET is a type I membrane protein receptor for Glial Cell Line-Derived Neurotrophic Factor with an extracellular cadherin-like domain and important in neural crest development. Activation of the RET kinase results in autophosphorylation of tyrosine residues critical for signaling. RET mutations are associated with Hirschsprung's disease and Multiple Endocrine Neoplasia, pheochromocytoma, hyperparathyroidism and medullary thyroid cancer. ( NCI )] (UMLS (NCI) C0919475) Glial Cell Line Derived Neurotrophic Factor Receptor Component; Hydroxyaryl-Protein Kinase; RET; RET Gene Product; RET Protein; Tyrosine-Protein Kinase Receptor RET; =Amino Acid, Peptide, or Protein; Enzyme
321. CA IN SITU SKIN EAR [ ] (UMLS (ICD9CM) C0347139) =Neoplastic Process	371. Cadherin, EGF LAG Seven-Pass G-Type Receptor 1 (Flamingo Homolog, Drosophila) Gene [This gene plays a role in cellular contact-mediated communication and embryonic regulation. ( NCI )] (UMLS (NCI) C1332751) CELSR1; CELSR1 Gene; =Gene or Genome ;
322. CA IN SITU SKIN FACE NEC (UMLS (ICD9CM) C0154077) =Neoplastic Process	372. Cadherin-1 [Encoded by human CDH1 Gene (CDH Family), 882-amino acid 97 kD (precursor) invasion suppressor type I membrane protein E-Cadherin is the main homodimeric Ca(2+)-dependent cell-cell adhesion glycoprotein in non-neural epithelia. Structurally similar to immunoglobulins, E-cadherin contains five extracellular cadherin repeats, a transmembrane region, and a conserved cytoplasmic tail required for internalization. E-Cadherin acts as ligand for integrin Alpha-E/Beta-7. CDH1 defects cause Familial Gastric Cancer. CDH1 mutations are correlated with breast, colorectal, thyroid, and ovarian cancer. E-cadherin down regulation often correlates with invasive potential and poor prognosis of human carcinomas; it is likely a main event in cancer proliferation, invasion, and metastasis, due to dysfunction of cell-cell adhesion. (from LocusLink, SWISS-PROT, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0042172) =Amino Acid, Peptide, or Protein; Biologically Active Substance
323. CA IN SITU SKIN LEG (UMLS (ICD9CM) C0154081) =Neoplastic Process	373. Cadherin-2 [Human Neural-cadherin is encoded by the CDH2 gene. The gene product is 906 amino acids and ~100kD in size. This protein plays a role in calcium-dependent cell adhesion. ( NCI )] (UMLS (NCI) C0027215) =Amino Acid, Peptide, or Protein; Biologically Active Substance
324. CA IN SITU SKIN LIP (UMLS (ICD9CM) C0154074) =Neoplastic Process	374. Cadherin-3 [Encoded by human CDH3 Gene (CDH Family), 829-amino acid 91 kD (precursor) Placental Cadherin is a homophilic Ca(2+)-dependent cell-cell adhesion type I membrane glycoprotein comprised of five extracellular cadherin repeats, a transmembrane region, and a highly conserved cytoplasmic tail. Aberrant expression is observed in cervical adenocarcinomas. Hypotrichosis with juvenile macular dystrophy is caused by production of a truncated protein resulting from a homozygous nucleotide deletion. (from SWISS-PROT, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0030128) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
325. CA IN SITU SKIN NEC (UMLS (ICD9CM) C0154082) =Neoplastic Process	375. cadmium [heavy metal element with atomic symbol Cd, atomic number 48, and atomic weight 114; cadmium and its salts are poisonous. ( CSP )] (UMLS (CSP) C0006632) =Hazardous or Poisonous Substance; Element, Ion, or Isotope ; =heavy metal;
326. CA IN SITU SKIN NOS [Stage 0: Tis: Carcinoma in situ; N0: No regional lymph node metastasis; M0: No distant metastasis. (Based on AJCC Cancer Staging). - 2002 ( NCI )] (UMLS (ICD9CM) C0154073) =Neoplastic Process	376. Cadmium Chloride [A whitish, crystalline, inorganic compound that forms toxic fumes of cadmium oxides when heated. Cadmium chloride is used in electroplating, printing, photocopying, dyeing, mirrors, vacuum tubes, lubricants, analytical chemistry and as a chemical intermediate to produce cadmium containing pigments and stabilizers. Exposure to this substance irritates the eyes, skin and respiratory tract and causes damage to the lungs resulting in shortness of breath, chest pain and pulmonary edema, and can also damage the kidneys causing proteinuria and decreased renal function. Cadmium chloride is a known carcinogen and is associated with an elevated risk of developing lung cancer. (NCI05) ( NCI )] (UMLS (NCI) C0054412) =Hazardous or Poisonous Substance; Inorganic Chemical ;
327. CA IN SITU SKIN TRUNK (UMLS (ICD9CM) C0154079) =Neoplastic Process	377. Cadmium Compound [An inorganic substance that contains the metallic element cadmium usually in its positive-2 valence state and forms toxic fumes of cadmium oxide when heated. Cadmium compounds are used in industry in electroplating and coating, in pigments, in batteries, in alloys, and as stabilizers. Exposure to these substances affects the lungs and kidneys and is associated with an increased risk of developing lung cancer. (NCI05) ( NCI )] (UMLS (NCI) C0303174) =Inorganic Chemical
328. CA IN SITU STOMACH [Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ: intraepithelial tumor without invasion of the lamina propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) - 2003 ( NCI )] (UMLS (ICD9CM) C0154060) =Neoplastic Process	378. Cadmium Nitrate [A colorless, crystalline, inorganic compound that forms toxic fumes of cadmium oxides when heated. Calcium nitrate is used in the production of cadmium hydroxide for use in alkaline batteries, to color glass and porcelain, in photography and in nuclear reactors. Exposure to this substance irritates the eyes, skin and respiratory tract and causes damage to the lungs resulting in shortness of breath, chest pain and pulmonary edema, and can also damage the kidneys causing proteinuria and decreased renal function. Calcium nitrate is a known carcinogen and is associated with an elevated risk of developing lung cancer. (NCI05) ( NCI )] (UMLS (NCI) C0054413) =Hazardous or Poisonous Substance; Inorganic Chemical ;
329. CA IN SITU TRACHEA (UMLS (ICD9CM) C0154070) =Neoplastic Process	379. Cadmium Oxide [A dark brown colored, crystalline, inorganic compound that forms toxic fumes of cadmium oxides when heated. Calcium oxide is mainly used in nickel-cadmium batteries, but is also used in electroplating, in the production of plastics and nitrile rubbers and as a nematocide and ascaricide in swine. Exposure to this substance irritates the eyes, skin and respiratory tract and causes damage to the lungs resulting in shortness of breath, chest pain and pulmonary edema, and can also damage the kidneys causing proteinuria and decreased renal function. Calcium oxide is a known carcinogen and is associated with an elevated risk of developing lung cancer. (NCI05) ( NCI )] (UMLS (NCI) C0054414) =Hazardous or Poisonous Substance; Inorganic Chemical ;
330. CA IN SITU URINARY NEC [ ] (UMLS (ICD9CM) C0154092) =Neoplastic Process	380. Cadmium Sulfate [A whitish, crystalline, inorganic compound that forms toxic fumes of cadmium oxides when heated. Calcium sulfate is used in electroplating, vacuum tubes, fluorescent screens, analytical chemistry, as a fungicide and as a chemical intermediate to produce cadmium containing pigments and stabilizers. Exposure to this substance irritates the eyes, skin and respiratory tract and causes damage to the lungs resulting in shortness of breath, chest pain and pulmonary edema, and can also damage the kidneys causing proteinuria and decreased renal function. Calcium sulfate is a known carcinogen and is associated with an elevated risk of developing lung cancer. (NCI05) ( NCI )] (UMLS (NCI) C0054416) =Hazardous or Poisonous Substance; Inorganic Chemical ;
331. CA IN SITU UTERUS NEC [ ] (UMLS (ICD9CM) C0154086) =Neoplastic Process	381. Cadmium Sulfide [A yellow to orange colored, crystalline, inorganic compound that forms toxic fumes of cadmium oxides when heated. Calcium sulfide is used as pigment in paints, plastics, textiles, ceramic and glass and is also used in solar cells, smoke and radiation detectors, light-emitting diodes and photomultipliers. Exposure to this substance irritates the eyes, skin and respiratory tract and causes damage to the lungs resulting in shortness of breath, chest pain and pulmonary edema, and can also damage the kidneys causing proteinuria and decreased renal function. Calcium sulfide is a known carcinogen and is associated with an elevated risk of developing lung cancer. (NCI05) ( NCI )] (UMLS (NCI) C0054417) =Hazardous or Poisonous Substance; Inorganic Chemical ;
332. Ca-DTPA [A drug that protects healthy tissues from the toxic effects of anticancer drugs. ( NCI )] (UMLS (NCI) C0520458) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid =GLYCINE; Organometallic Compound; [AD300] HEAVY METAL ANTAGONISTS; =PENTETATE CALCIUM TRISODIUM 20.6 MG; PENTETATE CALCIUM TRISODIUM 3 MG;	382. cADPR hydrolase [EC 3.2.2.5 ( MSH )] (UMLS (CSP) C0217585) =Amino Acid, Peptide, or Protein; Enzyme ;
333. CA1/CA2/CA3/CA4 brain regions [ ] (UMLS (CSP) C0872337) =Body Part, Organ, or Organ Component ;	383. Caecal Carcinoid Tumor (UMLS (NCI) C0854488) Caecum Carcinoid Tumor; Carcinoid Neoplasm of Cecum; Carcinoid Neoplasm of the Cecum; Carcinoid Tumor of Cecum; Carcinoid Tumor of the Cecum; Cecal Carcinoid Neoplasm; Cecal Carcinoid Tumor; Cecum Carcinoid Tumor =Neoplastic Process
334. CA15-3 Antigen [A protein/sugar compound made by some cancer cells. ( NCI )] (UMLS (NCI) C0006611) =Carbohydrate; Immunologic Factor ;	384. Caelyx [Pegylated liposomal doxorubicin hydrochloride. ( MSH )] (UMLS (NCI) C0701183) =Organic Chemical; Pharmacologic Substance ;
335. CA19-9 [A carbohydrate antigenic moiety that consists of proteins with sialylated lacto-N-fucopentose II decoration. Cancer antigen 19-9 (CA 19-9) is a protein that exists on the surface of tumor cells, and is cleaved in a process called tumor shedding. Clinically, it is a useful protein marker that is used to follow the course of persons with cancer; and is especially utilized in advanced pancreatic cancers. ( NCI )] (UMLS (NCI) C0006613) =Carbohydrate; Immunologic Factor ;	385. CAEV [A species of LENTIVIRUS, subgenus ovine-caprine lentiviruses (LENTIVIRUSES, OVINE-CAPRINE), closely related to VISNA-MAEDI VIRUS and causing acute encephalomyelitis; chronic arthritis; PNEUMONIA; MASTITIS; and GLOMERULONEPHRITIS in goats. It is transmitted mainly in the colostrum and milk. ( MSH )] (UMLS (CSP) C0079082) =Virus
336. cA2 [A monoclonal antibody that blocks the action of a cytokine called tumor necrosis factor alfa. It is being studied in the treatment and prevention of weight loss and loss of appetite in patients with advanced cancer. It belongs to the family of drugs called monoclonal antibodies. ( NCI )] (UMLS (NCI) C0666743) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor	386. CAF [A country in Central Africa, north of Democratic Republic of the Congo. (NCI) ( NCI )] (UMLS (NCI) C0007673) =Geographic Area ;
337. Ca2+ transporting ATPase [family of ATP-driven, transmembrane molecular pumps which maintain concentration gradients of calcium across a variety of cell membranes, the most notable being sarcoplasmic reticulum term not valid for FY 92. ( CSP )] (UMLS (CSP) C0001476) =Amino Acid, Peptide, or Protein; Enzyme ;	387. CAF (UMLS (NCI) C0054427) =Therapeutic or Preventive Procedure
338. Ca42 isotope [ ] (UMLS (CSP) C0598042) =Element, Ion, or Isotope ;	388. CAF/TsAVbH (UMLS (NCI) C0280277) =Therapeutic or Preventive Procedure
339. Ca44 isotope [ ] (UMLS (CSP) C0598043) =Element, Ion, or Isotope ;	389. Cafe Au Lait Patch [Light brown pigmented macules associated with NEUROFIBROMATOSIS and Albright's syndrome (see FIBROUS DYSPLASIA, POLYOSTOTIC). ( MSH )] (UMLS (NCI) C0221263) =Disease or Syndrome ; =Skin Manifestations; Pigmentation Disorders
340. Ca45 isotope [ ] (UMLS (CSP) C0303383) =Indicator, Reagent, or Diagnostic Aid; Element, Ion, or Isotope ;	390. Caffeina Citrata [Commercial citrate of caffeine, though not a definite salt. It is the alkaloid caffeine, with a portion of adherent citric acid, as indicated by its pharmacopoeial. name (citrated caffeine). Its general action and uses are the same as those given under caffeine. Caffeine citrate is used chiefly as a remedy for the idiopathic headache (migraine). This salt is very soluble in water, and is assimilated much more readily than pure caffeine when taken into the stomach. (NCI04) ( NCI )] (UMLS (NCI) C0054436) =Organic Chemical; Pharmacologic Substance ; =1,3,7-trimethylxanthine; [TN410] CITRATES; [CN809] CNS STIMULANTS, OTHER; =caffeine citrate 65 MG; CITRATED CAFFEINE 25 MG;
341. Ca46 isotope [ ] (UMLS (CSP) C0598044) =Indicator, Reagent, or Diagnostic Aid; Element, Ion, or Isotope	391. CAFP (UMLS (NCI) C0279419) =Therapeutic or Preventive Procedure
342. Ca47 isotope [ ] (UMLS (CSP) C0303384) =Indicator, Reagent, or Diagnostic Aid; Element, Ion, or Isotope ;	392. CAFTH (UMLS (NCI) C0279255) =Therapeutic or Preventive Procedure ;
343. CA4P [An anticancer drug that reduces the blood supply to tumors; it is a tubulin-binding agent. ( NCI )] (UMLS (NCI) C0796467) Combretastatin A4 Phosphate; Combretastatin A4 Prodrug; =Organic Chemical; Pharmacologic Substance ;	393. CAFVP (UMLS (NCI) C0054438) =Therapeutic or Preventive Procedure
344. CA4PD (UMLS (NCI) C0962508) Combretastatin A4 Disodium Phosphate; =Organic Chemical; Pharmacologic Substance ;	394. CAGA [Constitutively expressed in epithelial cells and in macrophages during chronic inflammation by human S100A8 Gene (S100 Family), 93-aa 11-kDa homodimeric S100 Calcium Binding Protein A8, containing 2 EF-hand calcium-binding motifs, may interact with intermediate filament components and function in casein kinase inhibition. (NCI) ( NCI )] (UMLS (NCI) C0054504) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
345. CAAF1 [Expressed in monocytes and lymphocytes by human S100A12 Gene (S100 Family), 91-aa 10-kDa (precursor) homodimeric S100 Calcium Binding Protein A12, containing 2 EF-hand calcium-binding motifs, is involved in regulatory effects on cytoskeletal components and in calcium-dependent signal transduction pathways. (NCI) ( NCI )] (UMLS (NCI) C0389073) =Amino Acid, Peptide, or Protein; Biologically Active Substance	395. CAGB [Constitutively expressed in epithelial cells and in macrophages within inflamed tissues by human S100A9 Gene (S100 Family), 114-aa 13-kDa S100 Calcium Binding Protein A9, containing 2 EF-hand calcium-binding motifs, may inhibit protein kinases and interact with intermediate filament components. Altered expression of S100A9 is associated with cystic fibrosis. (NCI) ( NCI )] (UMLS (NCI) C0054505) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
346. Cabazon Band of Cahuilla Mission Indians of the Ca (UMLS (HL7) C1554243) =Population Group =NativeEntityContiguous;	396. cage molecule [ ] (UMLS (CSP) C0599723) =Organic Chemical ;
347. cabbage [ ] (UMLS (CSP) C0006619) =Food	397. Cahitan (UMLS (HL7) C1699688) =Language =Taracahitan; =Yaqui
348. Cable [An external limb prosthetic component is a device intended for medical purposes that, when put together with other appropriate components, constitutes a total prosthesis. Examples of external limb prosthetic components include the following: Ankle, foot, hip, knee, and socket components; mechanical or powered hand, hook, wrist unit, elbow joint, and shoulder joint components; and cable and prosthesis suction valves. ( SPN )] (UMLS (NCI) C0492124) =Medical Device	398. Cahto Indian Tribe of the Laytonville Rancheria, C (UMLS (HL7) C1554247) =Population Group =NativeEntityContiguous;
349. CAC (UMLS (NCI) C0279290) =Therapeutic or Preventive Procedure ;	399. Cahuilla (UMLS (HL7) C1551978) =Language =Cupan;
350. cachectin [serum glycoprotein produced by activated macrophages and other mammalian mononuclear leukocytes; has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants; shares two receptors with tumor necrosis factor beta. ( CSP )] (UMLS (CSP) C1456820) TNF; TNF alpha; TNFA; TNF-Alpha; Tumor Necrosis Factor; Tumor Necrosis Factor Alpha; Tumor Necrosis Factor-Alpha; Tumor Necrosis Factor-alpha (macrophage-derived) =Amino Acid, Peptide, or Protein; Immunologic Factor =monokine;	400. Cahuilla Band of Mission Indians of the Cahuilla R (UMLS (HL7) C1554246) =Population Group =NativeEntityContiguous;

Buy website

Medical Clinic. Optician. Pharmacy. Physician. Travel Agency. Hotel reservation. Child Care. Education. Teachers. Lessons. Tests and Exams. Certification. Shopping Center. Store. Real Estate.
Affordable prices from $100.